Breast Imaging Market by Technology [Ionizing (FFDM, Analog, 3D Mammogram, CT, CBCT), Non-Ionizing (Breast Ultrasound, Breast MRI, AWBU, Breast Thermography)], End User (Hospital, Diagnostic Imaging Center), and Geography - Forecast to 2027

  • Report ID:MRHC - 104254
  • Pages: 209
  • Jun 2020
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours

1. Introduction  
    1.1. Market Definition 
    1.2. Market Ecosystem 
    1.3. Currency 
    1.4. Key Stakeholders 

2. Research Methodology 
    2.1. Research Approach 
    2.2. Data Collection & Validation 
           2.2.1. Secondary Research 
           2.2.2. Primary Research 
    2.3. Market Assessment 
           2.3.1. Market Size Estimation 
                     2.3.1.1. Bottom-Up Approach 
                     2.3.1.2. Top-Down Approach 
                     2.3.1.3. Growth Forecast 
           2.3.2. Market Share Analysis 
    2.4. Assumptions for the Study 
    2.5. Limitations for the Study 

3. Executive Summary 

4. Market Insights 
    4.1. Introduction 
    4.2. Drivers 
           4.2.1. Rising Prevalence and Incidence of Breast Cancer 
           4.2.2. Growing Awareness for Early Detection of Breast Diseases 
           4.2.3. Technological Innovations and Launch of Advanced Breast Imaging Equipment & Software
           4.2.4. Increasing Investment and Funding in R&D for Breast Cancer Treatments 
           4.2.5. Rising Women Aging Population 
    4.3. Restraints 
           4.3.1. High Cost of Breast Imaging Equipment 
           4.3.2. Stringent Regulatory Approval Procedure 
    4.4. Opportunities 
           4.4.1. Extensive Research in the Development of Hybrid Imaging Systems 
    4.5. Challenge 
           4.5.1. Errors Associated with Breast Screening and Diagnosing 
           4.5.2. Increasing Adoption of Refurbished Products 
    4.6. Impact of COVID-19 on the Breast Imaging Market

5. Global Breast Imaging Market, by Technology 
    5.1. Introduction 
    5.2. Ionizing Technology 
           5.2.1. Full-Field Digital Mammography (FFDM)   
           5.2.2. Analog Mammography 
           5.2.3. 3D Breast Tomosynthesis
           5.2.4. Positron Emission Tomography/Computed Tomography (PET/CT) 
           5.2.5. Molecular Breast-Specific Gamma Imaging (MBI/BSGI) 
           5.2.6. Positron Emission Mammography (PEM)
           5.2.7. Computed Tomography (CT)
           5.2.8. Cone Beam Computed Tomography (CBCT) 
    5.3. Non- Ionizing Technology 
           5.3.1. Breast Ultrasound 
           5.3.2. Breast MRI 
           5.3.3. Automated Whole-Breast Ultrasound (AWBS)            
           5.3.4. Breast Thermography 
           5.3.5. Optical Imaging 

6. Global Breast Imaging Market, by End User 
    6.1. Introduction
    6.2. Hospitals 
    6.3. Diagnostic Imaging Centers 
    6.4. Ambulatory Surgical Centers (ASCs) 

7. Breast Imaging Market, by Geography 
    7.1. Introduction 
    7.2. North America 
           7.2.1. U.S. 
           7.2.2. Canada 
    7.3. Europe 
           7.3.1. Germany 
           7.3.2. France 
           7.3.3. U.K. 
           7.3.4. Italy 
           7.3.5. Spain 
           7.3.6. Rest of Europe (RoE)
    7.4. Asia-Pacific 
           7.4.1. Japan 
           7.4.2. China 
           7.4.3. India 
           7.4.4. Australia 
           7.4.5. Rest of Asia-Pacific 
    7.5. Latin America 
    7.6. Middle East & Africa 

8. Competitive Landscape 
    8.1. Introduction 
    8.2. Key Growth Strategies 
    8.3. Competitive Benchmarking 
    8.4. Market Share Analysis (2019) 
           8.4.1. GE Healthcare (U.S.) 
           8.4.2. Hologic, Inc. (U.S.) 
           8.4.3. Siemens Healthineers AG (Germany) 

9. Company Profile 
    9.1. GE Healthcare 
           9.1.1. Business Overview 
           9.1.2. Financial Overview 
           9.1.3. Product Portfolio 
           9.1.4. Strategic Developments 
                    9.1.4.1. New Product Launches 
                    9.1.4.2. Agreements, and Partnerships 
    9.2. Hologic, Inc. 
           9.2.1. Business Overview 
           9.2.2. Financial Overview 
           9.2.3. Product Portfolio 
           9.2.4. Strategic Developments 
                    9.2.4.1. New Product Launches & Approvals 
                    9.2.4.2. Agreements, Partnerships, and Collaborations 
                    9.2.4.3. Acquisitions
    9.3. Siemens Healthineers AG (Subsidiary of Siemens AG) 
           9.3.1. Business Overview 
           9.3.2. Financial Overview 
           9.3.3. Product Portfolio 
           9.3.4. Strategic Developments 
                    9.3.4.1. Product Launches 
                    9.3.4.2. Partnerships and Agreements 
                    9.3.4.3. Expansion 
    9.4. Carestream Health, Inc. 
           9.4.1. Business Overview 
           9.4.2. Product Portfolio 
           9.4.3. Strategic Developments  
                    9.4.3.1. Expansion 
    9.5. Koninklijke Philips N.V. 
           9.5.1. Business Overview 
           9.5.2. Financial Overview
           9.5.3. Product Portfolio 
           9.5.4. Strategic Developments 
                    9.5.4.1. New Product Launches 
                    9.5.4.2. Agreements, Partnerships, and Collaborations 
    9.6. Fujifilm Holdings Corporation 
           9.6.1. Business Overview 
           9.6.2. Financial Overview 
           9.6.3. Product Portfolio 
           9.6.4. Strategic Developments 
                    9.6.4.1. Product Approval 
                    9.6.4.2. Agreement 
    9.7. Canon Medical Systems Corporation (Subsidiary of Canon Inc.) 
           9.7.1. Business Overview 
           9.7.2. Financial Overview 
           9.7.3. Product Portfolio 
           9.7.4. Strategic Developments 
                    9.7.4.1. Product Launches 
                    9.7.4.2. Agreements, Partnerships, and Collaborations 
                    9.7.4.3. Acquisition 
                    9.7.4.4. Expansion 
    9.8. Hitachi Medical Corporation (Subsidiary of Hitachi, Ltd.) 
           9.8.1. Business Overview 
           9.8.2. Financial Overview 
           9.8.3. Product Portfolio 
           9.8.4. Strategic Developments 
                    9.8.4.1. Agreement 
    9.9. Aurora Healthcare US Corp 
           9.9.1. Business Overview 
           9.9.2. Product Portfolio 
   9.10. Dilon Technologies, Inc. 
           9.10.1. Business Overview 
           9.10.2. Product Portfolio 
   9.11. CMR Naviscan Corporation 
            9.11.1. Business Overview 
            9.11.2. Product Portfolio 
    9.12. Planmed Oy 
             9.12.1. Business Overview 
             9.12.2. Product Portfolio 
             9.12.3. Strategic Developments 
                        9.12.3.1. Product Launches & Approvals 
                        9.12.3.2. Agreements, Collaborations, and Partnerships 
                        9.12.3.3. Product Enhancements 
    9.13. SonoCine Inc. 
             9.13.1. Business Overview 
             9.13.2. Product Portfolio 

10. Appendix 
      10.1. Questionnaire 
      10.2. Available Customization 

List of Tables 

Table 1 Global Breast Imaging Market Drivers: Impact Analysis (2020-2027)
Table 2 Global Breast Imaging Market Restraints: Impact Analysis (2020-2027)
Table 3 Cost of Breast Imaging Technologies
Table 4 Average Price of Mammography Systems
Table 5 Global Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 6 Global Ionizing Breast Imaging Technologies Market, by Type, 2018-2027 ($Million)
Table 7 Global Ionizing Breast Imaging Technologies Market, by Type, 2018-2027 (Units)
Table 8 Global Ionizing Breast Imaging Technologies Market, by Region/Country, 2018-2027 ($Million)
Table 9 List of Key Vendors Offering FFDM Products
Table 10 Global FFDM Market, by Region/Country, 2018-2027 ($Million)
Table 11 Global FFDM Market, by Region/Country, 2018-2027 (Units)
Table 12 Key Vendors Offering Analog Mammography Products
Table 13 Global Analog Mammography Market, by Region/Country, 2018-2027 ($Million)
Table 14 Global Analog Mammography Market, by Region/Country, 2018-2027 (Units)
Table 15 List of Key Vendors Offering 3DBT Products
Table 16 FDA Approved 3DBT Systems
Table 17 Global 3DBT Market, by Region/Country, 2018-2027 ($Million)
Table 18 Global 3DBT Market, by Region/Country, 2018-2027 (Units)
Table 19 Global PET/CT Market, by Region/Country, 2018-2027 ($Million)
Table 20 Global PET/CT Market, by Region/Country, 2018-2027 (Units)
Table 21 List of Key Vendors Offering MBI/BSGI Products
Table 22 Global MBI/BSGI Market, by Region/Country, 2018-2027 ($Million)
Table 23 Global MBI/BSGI Market, by Region/Country, 2018-2027 (Units)
Table 24 List of Key Vendors Offering PEM Products
Table 25 Global PEM Market, by Region/Country, 2018-2027 ($Million)
Table 26 Global PEM Market, by Region/Country, 2018-2027 (Units)
Table 27 List of Key Vendors Offering Ct Products
Table 28 Global Ct Systems Market, by Region/Country, 2018-2027 ($Million)
Table 29 Global Ct Systems Market, by Region/Country, 2018-2027 (Units)
Table 30 Key Vendors Offering CBCT Products
Table 31 Global CBCT Systems Market, by Region/Country, 2018-2027 ($Million)
Table 32 Global CBCT Systems Market, by Region/Country, 2018-2027 (Units)
Table 33 Global Non-Ionizing Technologies Market, by Type, 2018-2027 ($Million)
Table 34 Global Non-Ionizing Technologies Market, by Type, 2018-2027 (Units)
Table 35 Global Non-Ionizing Technologies Market, by Region/Country, 2018-2027 ($Million)
Table 36 Key Vendors Offering Breast Ultrasound Products
Table 37 Global Breast Ultrasound Market, by Region/Country, 2018-2027 ($Million)
Table 38 Global Breast Ultrasound Market, by Region/Country, 2018-2027 (Units)
Table 39 List of Key Vendors Offering Breast MRI Products
Table 40 Global Breast MRI Market, by Region/Country, 2018-2027 ($Million)
Table 41 Global Breast MRI Market, by Region/Country, 2018-2027 (Units)
Table 42 List of Key Vendors Offering AWBU Products
Table 43 Global AWBU Systems Market, by Region/Country, 2018-2027 ($Million)
Table 44 Global AWBU Systems Market, by Region/Country, 2018-2027 (Units)
Table 45 Key Vendors Offering Breast Thermography Products
Table 46 Global Breast Thermography Market, by Region/Country, 2018-2027 ($Million)
Table 47 Global Breast Thermography Market, by Region/Country, 2018-2027 (Units)
Table 48 List of Key Vendors Offering Optical Imaging Products
Table 49 Global Optical Imaging Market, by Region/Country, 2018-2027 ($Million)
Table 50 Global Optical Imaging Market, by Region/Country, 2018-2027 (Units)
Table 51 Global Breast Imaging Market Size, by End User, 2018-2027 ($Million)
Table 52 Global Breast Imaging Market for Hospitals, by Region/Country, 2018-2027 ($Million)
Table 53 Global Breast Imaging Market for Diagnostic Imaging Centers, by Region/Country, 2018-2027 ($Million)
Table 54 Global Breast Imaging Market for ASCs, by Region/Country, 2018-2027 ($Million)
Table 55 Global Breast Imaging Market, by Region/Country, 2018-2027 ($ Million)
Table 56 North America: Breast Imaging Market, by Country, 2018-2027 ($Million)
Table 57 North America: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 58 North America: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 59 North America: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 60 North America: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 61 North America: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 62 North America: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 63 North America: Breast Imaging Market, by End User, 2018-2027 ($Million)
Table 64 U.S.: Key Macroindicators
Table 65 U.S.: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 66 U.S.: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 67 U.S.: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 68 U.S.: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 69 U.S.: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 70 U.S.: Non-Ionizing Technology Market, by Technology, 2018-2027 (Units)
Table 71 U.S.: Breast Imaging Market, by End User, 2018-2027 ($Million)
Table 72 Canada: Key Macroindicators
Table 73 Canada: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 74 Canada: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 75 Canada: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 76 Canada: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 77 Canada: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 78 Canada: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 79 Canada: Breast Imaging Market Size, by End User, 2018-2027 ($Million)
Table 80 Europe: Breast Imaging Market, by Country, 2018-2027 ($Million)
Table 81 Europe: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 82 Europe: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 83 Europe: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 84 Europe: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 85 Europe: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 86 Europe: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 87 Europe: Breast Imaging Market Size, by End User, 2018-2027 ($Million)
Table 88 Germany: Key Macroindicators
Table 89 Germany: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 90 Germany: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 91 Germany: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 92 Germany: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 93 Germany: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 94 Germany: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 95 Germany: Breast Imaging Market Size, by End User, 2018-2027 ($Million)
Table 96 France: Key Macroindicators
Table 97 France: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 98 France: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 99 France: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 100 France: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 101 France: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 102 France: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 103 France: Breast Imaging Market, by End User, 2018-2027 ($Million)
Table 104 Number of Imaging Examinations Performed in The U.K.: 2012-2019
Table 105 U.K.: Key Macroindicators
Table 106 U.K.: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 107 U.K.: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 108 U.K.: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 109 U.K.: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 110 U.K.: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 111 U.K.: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 112 U.K.: Breast Imaging Market Size, by End User, 2018-2027 ($Million)
Table 113 Italy: Key Macroindicators
Table 114 Italy: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 115 Italy: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 116 Italy: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 117 Italy: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 118 Italy: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 119 Italy: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 120 Italy: Breast Imaging Market Size, by End User, 2018-2027 ($Million)
Table 121 Spain: Key Macroindicators
Table 122 Spain: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 123 Spain: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 124 Spain: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 125 Spain: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 126 Spain: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 127 Spain: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 128 Spain: Breast Imaging Market Size, by End User, 2018-2027 ($Million)
Table 129 RoE: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 130 RoE: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 131 RoE: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 132 RoE: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 133 RoE: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 134 RoE: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 135 RoE: Breast Imaging Market Size, by End User, 2018-2027 ($Million)
Table 136 Asia Pacific: Breast Imaging Market, by Country, 2018-2027 ($Million)
Table 137 Asia-Pacific: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 138 Asia-Pacific: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 139 Asia-Pacific: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 140 Asia-Pacific: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 141 Asia-Pacific: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 142 Asia-Pacific: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 143 Asia-Pacific: Breast Imaging Market, by End User, 2018-2027 ($Million)
Table 144 Japan: Key Macroindicators
Table 145 Japan: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 146 Japan: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 147 Japan: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 148 Japan: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 149 Japan: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 150 Japan: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 151 Japan: Breast Imaging Market, by End User, 2018-2027 ($Million)
Table 152 China: Key Macroindicators
Table 153 China: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 154 China: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 155 China: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 156 China: Ionizing Thechnology Market, by Type, 2018-2027 (Units)
Table 157 China: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 158 China: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 159 China: Breast Imaging Market, by End User, 2018-2027 ($Million)
Table 160 India: Key Macroindicators
Table 161 India: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 162 India: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 163 India: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 164 India: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 165 India: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 166 India: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 167 India: Breast Imaging Market, by End User, 2018-2027 ($Million)
Table 168 Australia: Key Macroindicators
Table 169 Australia: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 170 Australia: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 171 Australia: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 172 Australia: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 173 Australia: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 174 Australia: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 175 Australia: Breast Imaging Market Size, by End User, 2018-2027 ($Million)
Table 176 New Breast Cancer Cases in RoAPAC: 2018-2040
Table 177 RoAPAC: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 178 RoAPAC: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 179 RoAPAC: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 180 RoAPAC: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 181 RoAPAC: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 182 RoAPAC: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 183 RoAPAC: Breast Imaging Market Size, by End User, 2018-2027 ($Million)
Table 184 Latin America: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 185 Latin America: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 186 Latin America: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 187 Latin America: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 188 Latin America: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 189 Latin America: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 190 Latin America: Breast Imaging Market Size, by End User, 2018-2027 ($Million)
Table 191 Middle East & Africa: Breast Imaging Market, by Technology, 2018-2027 ($Million)
Table 192 Middle East & Africa: Breast Imaging Market, by Technology, 2018-2027 (Units)
Table 193 Middle East & Africa: Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 194 Middle East & Africa: Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 195 Middle East & Africa: Non-Ionizing Technology Market, by Type, 2018-2027 ($Million)
Table 196 Middle East & Africa: Non-Ionizing Technology Market, by Type, 2018-2027 (Units)
Table 197 Middle East & Africa: Breast Imaging Market, by End User, 2018-2027 ($Million)
Table 198 Number of Developments by The Major Players During 2016-2020

List of Figures

Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Breast Imaging Market, by Technology, 2020 Vs. 2027
Figure 8 Breast Imaging Market, by End User, 2020 Vs. 2027
Figure 9 Breast Imaging Market, by Region
Figure 10 Market Dynamics
Figure 11 Number of New Breast Cancer Cases: 2012-2035
Figure 12 Female Population Aged 65 Years or Above (As % of Total Female Population), 2013-2018
Figure 13 Global Breast Imaging Market, by Technology, 2020-2027 ($Million)
Figure 14 Global Breast Imaging Market Size, by End User, 2020-2027 ($Million)
Figure 15 Total Number of Registered Hospitals in The U.S., 2018-2019
Figure 16 Number of Ambulatory Surgical Centres (ASCs) Across the U.S., 2011-2019
Figure 17 Global Breast Imaging Market, By Geography, 2020-2027 ($Million)
Figure 18 North America: Breast Imaging Market Snapshot
Figure 19 Number of New Breast Cancer Cases in U.S.: 2018-2035
Figure 20 Number of New Breast Cancer Cases in Canada: 2014-2030
Figure 21 Number of Imaging Units Installed in Canada: 2007 Vs. 2017
Figure 22 Europe: Breast Imaging Market Snapshot
Figure 23 New Breast Cancer Cases in Germany: 2012-2035
Figure 24 New Breast Cancer Cases in France: 2018-2030
Figure 25 Number of New Breast Cancer Cases in U.K.: 2018-2035
Figure 26 New Breast Cancer Cases in Italy: 2018-2035
Figure 27 Mammography Machines Per 1,000,000 Inhabitants in Italy: 2012 Vs. 2017
Figure 28 Female Population Aged 65 And Over in Spain (As % of Total Female Population): 2012-2018
Figure 29 Breast Cancer Incidence, by Country: 2018 Vs. 2030
Figure 30 Per Capita Health Spending, by Country, 2018 (In $)
Figure 31 Asia-Pacific: Breast Imaging Market Snapshot
Figure 32 New Breast Cancer Cases in Japan: 2012 Vs. 2018
Figure 33 New Breast Cancer Cases in China: 2012-2035
Figure 34 New Breast Cancer Cases in India: 2012-2035
Figure 35 New Breast Cancer Cases in Australia: 2013-2035
Figure 36 New Breast Cancer Cases in Latin America: 2018 Vs. 2030
Figure 37 Key Growth Strategies Adopted by Leading Players (2016-2020)
Figure 38 Breast Imaging: Competitive Benchmarking
Figure 39 Market Share Analysis: Breast Imaging Market (2019)
Figure 40 Ge Healthcare: Financial Overview (2019)
Figure 41 Hologic, Inc.: Financial Overview (2019)
Figure 42 Siemens Healthineers Ag: Financial Overview (2019)
Figure 43 Koninklijke Philips N.V.: Financial Overview (2019)
Figure 44 Fujifilm Holdings Corporation: Financial Overview (2019)
Figure 45 Canon, Inc.: Financial Overview (2019)
Figure 46 Hitachi, Ltd.: Financial Overview (2019) 

COVID-19

This report provides pre & post COVID-19 market estimates

Download sample here

The breast imaging market is expected to grow at a CAGR of 9% from 2020 to 2027 to reach $7.08 billion by 2027. Breast imaging is a subspecialty of diagnostic radiology, which utilizes ionizing or non-ionizing radiation to detect tumor lesion in the breast. This technique enables the clinicians to conduct early diagnosis before the actual symptoms appear. The growth in this market is majorly driven by the rising prevalence and incidence of breast cancer, growing awareness for early detection of breast cancer and other related diseases, technological innovations and launch of advanced breast imaging equipment & software, increasing investment and funding in R&D for breast cancer treatment, and rising aging population of women. Further, the extensive research in the development of hybrid imaging systems offers significant growth opportunities for the players operating in the global breast imaging market.    

                                           Click here to: Get Free Request Sample Copy of this report

Impact of COVID-19 on the Breast Imaging Market

Due to recent outbreak of Novel Corona Virus (COVID-19), hospitals have limited resources and staff, which is the major reason for delay in some surgeries and other medical procedures. In severely affected regions, the influx of COVID-19 patients requiring continuous monitoring and ventilation is increasing rapidly, leading to overloading of hospital systems disrupting the routine treatment of cancer patients, whose conditions likely to be worsened if usual standard care is delayed. Moreover, in major markets, such as North America and Europe, continuous rise in COVID-19 cases has completely prohibited the movement of people, which led to delays in routine breast examinations related to cancer diagnosis and hence can impact the market to a certain extent. Further, reduced visits due to patient concerns related to COVID-19 and sequestering of oncology medical staff have resulted into replacement of outpatient visits with telephone consultation.

Furthermore, high rates of sickness among health workers due to COVID-19 are dramatically reducing the availability of medical staff. According to the World Health Organization (WHO), as of April 2020, the COVID-19 pandemic has hit over 22,000 healthcare workers across 52 countries, and in the U.S., the number of health care workers who tested positive for the coronavirus is likely to be far higher than the reported tally of 9,200. This increase is reducing the medical staff availability for cancer treatment which is negatively impacting the breast imaging market.

In addition, the purchasing of new equipment and its installations is completely hampered these days, which is also going to affect the market for the year 2020. Also, most of the parts and materials used in making of medical equipment are from China, and complete shutdown of trade from such countries has reduced the manufacturing of medical equipment including breast imaging systems, thereby hampering the growth of this market.

Rising prevalence and incidence of breast cancer is propelling the growth of the breast imaging Market           

In recent years, widespread use of hormone replacement therapy (HRT) following menopause, various reproductive disorders, and hormonal imbalances have significantly increased the risks of breast cancer. According to the Global Cancer Observatory (GLOBOCAN), the number of new breast cancer cases was reported to be 1,651,326 in 2012, which increased by 26.5%, reaching 2,088,849 in 2018. Further, these numbers are expected to increase to 2,407,748 and 2,853,857 new cases by 2025 and 2035 respectively. Similarly, deaths due to breast cancer are also expected to increase by more than 44% from 626,679 in 2018 to 904,805 by 2035. Owing to the increasing prevalence of breast cancer and associated mortalities, breast cancer detection and diagnosis is garnering significant attraction, globally.

Growing awareness for early detection of breast diseases supports the market growth

In recent years, the increasing prevalence of breast cancer and related mortality at young age and delayed presentation has alerted women to timely seek medical advice. In developing nations, many of the breast cancer cases are diagnosed at late stage due to lack of awareness about early warning signs and screening methods. Therefore, various organizations across the globe are carrying out the awareness programs and campaigns for the early detection of breast cancer. For instance:

  • In the U.S., National Breast Cancer Foundation, Inc. (a non-profit organization) organize National Mammography Program every year, which provides free mammograms and diagnostic services for early diagnosis and treatment of breast cancer.
  • In August 2019, Canadian Cancer Society announced its collaboration with Stand Up to Cancer Canada (SU2C Canada) and the Canadian Institutes of Health Research (CIHR) to launch the SU2C Canada Metastatic Breast Cancer Dream Team. This team received funding of $6 million to conduct nation-wide clinical trials and awareness programs to prevent and treat metastatic breast cancer.
  • In July 2019, the government of France announced the adoption of “Ma santé 2022" plan, which aims to reform healthcare system in the country. Under this plan, the government targeted to increase the number of medical professionals and to gear up the union of hospitals and local health care centers to provide quality care.

Such screening programs and initiatives are expected to increase the awareness related to diagnosis and treatment of breast cancer and would ultimately support the breast imaging market growth.

Extensive research in the development of hybrid imaging systems offer high growth opportunities and supports the market growth

Advances in imaging technologies in recent years have revolutionized the aspect of treatment and approach towards it. The combination of imaging technologies such as CT scans, MRIs, PET, and others have become increasingly important to visualize the metabolic information and anatomic details of the organs. Also, these integrated imaging modalities have improved the quality of breast images, patient comfort, and reduced the patient dose. Due to these benefits, manufacturers across the globe are focusing more on new product launches to increase the sensitivity and accuracy in breast cancer diagnostics.

Key Findings in the Global Breast Imaging Market Study:

Ionizing technology generated large proportion of revenue compared to other non-ionizing technologies

The ionizing technology segment is estimated to command the largest share of the overall breast imaging market in 2020. Incessant launches of breast imaging systems with ionizing technology, ongoing technological advancements in ionizing technology, and growing focus and investments of key players in development and improvement of this technology are the major factors increasing the adoption and demand for ionizing technology.

3D breast tomosynthesis to register the fastest growth in the breast imaging market for ionizing technology by 2027

The 3D breast tomosynthesis segment is slated to grow with the fastest CAGR during the forecast period. This growth is mainly due to the sharp image outcomes and decreased recall rates with this technology. Also, 3D breast tomosynthesis overcomes the limitation of standard mammography by aiding in detection of all lesion types.

Breast ultrasound to dominate the global breast imaging market for non-ionizing technology in 2020

Breast ultrasound is estimated to command the largest share of the overall breast imaging market for non-ionizing technology in 2020. Low risk of radiation exposure, higher sensitivity, and low-cost diagnosis are the key factors driving the growth of the breast ultrasound market.

On the basis of end user, hospitals to dominate the overall break imaging market in 2020

Hospitals are estimated to command the largest share of the overall breast imaging market in 2020. Increasing investments on healthcare infrastructure development, higher purchasing power, availability of well-equipped operating & diagnostic rooms, and better health coverage for hospital-based healthcare services are the key factors supporting the dominance of hospitals.

Asia-Pacific: The fastest growing regional market

North America is estimated to command the largest share of the global breast imaging market in 2020, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia-Pacific region will be the fastest growing regional market due to the accelerated economic growth of many countries in this region; increasing prevalence of breast cancer; and growing government focus towards improvement of healthcare sector. In addition, frequent breast screening programs to spread awareness related to importance of early diagnosis in the region is the other key factor propelling the growth of the Asia-Pacific breast imaging market.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2020). The key players profiled in the global breast imaging market report are Hologic, Inc. (U.S.), GE Healthcare (U.S.), Canon Inc. (Japan), Siemens AG (Germany), Koninklijke Philips N.V. (Netherlands), Carestream Health, Inc (U.S.), Planmed Oy (Finland), Hitachi, Ltd. (Japan),  Dilon Technologies Inc. (U.S.), CMR Naviscan Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Aurora Healthcare US Corp (U.S.), and SonoCine Inc. (U.S.).

Scope of the Report:

Breast Imaging Market by Technology

  • Ionizing Technology
    • Full-Field Digital Mammography (FFDM)
    • 3D Breast Tomosynthesis
    • Positron Emission Tomography/Computed Tomography (PET/CT)
    • Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
    • Computed Tomography (CT)
    • Positron Emission Mammography (PEM)
    • Analog Mammography
    • Cone Beam Computed Tomography (CBCT)   
  • Non-Ionizing Technology
    • Breast Ultrasound
    • Breast MRI
    • Automated Whole-Breast Ultrasound
    • Breast Thermography
    • Optical Imaging

Breast Imaging Market by End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Surgical Centers

Breast Imaging Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Australia
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report-

The global breast imaging market is projected to reach $7.08 billion by 2027, at a CAGR of 9.0% during the forecast period of 2020-2027
Based on technology, the non-ionizing technology segment accounted for the largest share of the global breast imaging market with its higher adoption for breast cancer screening, easy availability in the market since many decades, ongoing technological advancements in ionizing technology to offer better results, and emergence of new players with products based on ionizing technology.
The ambulatory surgical centers segment is projected to register the fastest CAGR during the forecast period, mainly due to the rising preference for outpatient services and quick arrangement of diagnostic examinations for critical breast cancer patient by eliminating the waiting time at hospitals.
Rising prevalence and incidence of breast cancer, growing awareness for early detection of breast diseases, technological innovations and launch of advanced breast imaging equipment & software, increasing investment and funding in R&D for breast cancer treatment, and rising women aging population provide significant growth opportunities for vendors across the globe.
The global breast imaging market is fragmented in nature and the key players, namely, GE Healthcare (U.S.), Hologic, Inc. (U.S.), and Siemens Healthineers AG (Germany) are the leading players in this market and are majorly driving the innovation trends in the market with their strategic developments.
Some of the prominent players operating in the breast imaging market Hologic, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthineers AG (Germany), Carestream Health, Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), Canon Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Aurora Healthcare US Corp (U.S.), Dilon Technologies, Inc. (U.S.), CMR Naviscan Corporation (U.S.), Planmed Oy (Finland), and SonoCine Inc. (U.S.).
The emerging economies like China and India in Asia Pacific region are projected to offer significant growth opportunities for the vendors in this market. Accelerated economic growth of many countries, growing government focus on healthcare sector, rising incidence & prevalence of breast tumor, increasing health insurance penetration, and rising female aging population in the Asia-Pacific region are the key factors supporting the projected fastest growth during the forecast period.
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Medical Technologies Imaging Technologies Connected Health / Digital Health Healthcare
Download Free Sample